This smallcap multibagger debutant has lost steam. Upside limited, say analysts
NEW DELHI: Shares of 2021 debutant Tatva Chintan Pharma Chem, which had rallied a whopping 134 per cent intraday on its market debut in July last year, have run out of steam. A likely tepid prospects for high-margin structure directing agents (SDA) segment, which accounted for 41 per cent of total revenues in the March … Read more